Medical Guide · PKU Therapy

PKU Treatment:
The 3 Pillars of Therapy

Treatment for phenylketonuria (PKU) rests on three complementary and equally important pillars: a low-phenylalanine diet, daily amino acid formula, and — where indicated — medical therapy. All three are essential and work together to keep blood phenylalanine in the therapeutic range.

ICD-10: E70.0
3 pillars of treatment
Lifelong therapy recommended
Regular blood Phe monitoring
⚕️
Important: This page provides general information about PKU treatment. Individual daily phenylalanine limits, formula dosing, and all treatment decisions are made exclusively by your metabolic specialist and registered dietitian. This content does not replace personalised medical advice.

The Three Pillars of PKU Treatment at a Glance

PKU (phenylketonuria) is an inherited metabolic disorder in which the enzyme phenylalanine hydroxylase (PAH) is absent or severely reduced. Without treatment, phenylalanine (Phe) accumulates in the blood and causes irreversible brain damage. Modern PKU therapy combines three complementary approaches — the balance between them depends on genotype and severity.

1

Low-Phenylalanine Diet

Strict restriction of natural protein. The cornerstone since 1953. Required lifelong.

2

Amino Acid Formula

Supplies all essential amino acids without Phe. Taken daily, 2–4 times. Not optional.

3

Medical Therapy

BH4/sapropterin or pegvaliase — depending on genotype and response. Complements the diet.

Pillar 1: Low-Phenylalanine Diet

The low-phenylalanine diet is the oldest and most fundamental pillar of PKU therapy — first used by Horst Bickel in 1953 and responsible for protecting generations of people with PKU from irreversible cognitive impairment. Its principle: reduce daily phenylalanine intake sufficiently to keep blood Phe within the therapeutic range.

Because phenylalanine is present in almost all natural proteins, the PKU diet requires strict restriction of high-protein foods including meat, fish, dairy products, pulses, nuts, and ordinary grain products. Many fruits and vegetables are permitted, as are specially formulated low-phenylalanine products.

  • Individual Phe tolerance varies considerably by severity — from below 200 mg Phe/day in classic PKU to over 600 mg/day in mild hyperphenylalaninaemia
  • The daily Phe limit is set individually by the metabolic centre and reviewed regularly as the patient grows or their condition changes
  • The diet must be maintained lifelong — the earlier recommendation to relax it after childhood is now considered scientifically obsolete and is no longer applied in clinical practice
  • Elevated Phe disrupts the synthesis of neurotransmitters including dopamine and serotonin, causing measurable cognitive and psychiatric impairment in adults as well as children
  • PHE Buddy automatically calculates daily phenylalanine intake — meal by meal, in real time — against the physician-set daily limit, using the BLS 4.0 database and an AI label scanner

Pillar 2: Amino Acid Formula

Because PKU patients may only consume very small amounts of natural protein, all essential amino acids must be supplied through a specialised amino acid mixture — commonly called metabolic formula. These products contain all essential amino acids without phenylalanine, making them the necessary companion to the low-Phe diet.

Formula is not an optional supplement — it is as essential as the diet itself. Without it, protein deficiency causes growth delays and cognitive developmental problems in children, and muscle loss, immune impairment, and further complications in adults.

  • Frequency: 2–4 times daily, spread evenly throughout the day — this optimises amino acid absorption and maintains a consistent plasma level
  • Formulations: available as powder (to mix with water), ready-to-drink liquid, or gel — depending on personal preference and tolerability
  • Age-specific products: dedicated formulas exist for infants, toddlers, school-age children, adolescents, adults, and pregnant women with PKU (maternal PKU)
  • Composition: most formulas also supply vitamins, minerals, and trace elements that are otherwise insufficient on a low-protein diet
  • PHE Buddy formula tracking: PHE Buddy logs daily formula intake, sends reminders for each scheduled dose, and generates compliance reports for clinic appointments

Pillar 3: Medical Therapy

For a proportion of PKU patients, pharmacological treatment is available to complement — or in some cases substantially liberalise — the diet. Which medication is appropriate depends on genotype, residual PAH enzyme activity, and individual response to treatment.

BH4 Therapy

Sapropterin (Kuvan®)

Sapropterin is a synthetic tetrahydrobiopterin (BH4) — the natural cofactor of the PAH enzyme. In BH4-responsive patients (approximately 20–30% of all PKU patients, predominantly milder forms with residual enzyme activity), sapropterin stabilises the remaining enzyme and increases its activity. This results in lower blood Phe levels and often a higher dietary Phe tolerance. Sapropterin is taken once daily as a tablet or dissolved powder. BH4-responsiveness is determined via a standardised 4-week loading test at a metabolic centre.

Enzyme Therapy

Pegvaliase (Palynziq®)

Pegvaliase is a recombinant, PEGylated phenylalanine ammonia lyase (PAL) enzyme — an enzyme substitution therapy approved for adults with classic PKU who do not respond adequately to diet and BH4. It is administered by subcutaneous injection, starting weekly and increasing in frequency over a titration phase of 6–12 months. Pegvaliase can dramatically reduce blood Phe — some patients achieve near-normal levels. Important: hypersensitivity reactions, including anaphylaxis, are possible; the therapy requires close monitoring. Approved in Germany, Austria, and Switzerland.

New therapies in development: Promising approaches in clinical trials include mRNA therapy (restoring PAH function via mRNA), gene therapy (direct correction of the PAH gene defect), and improved enzyme substitution strategies. PHE Buddy will notify users when new approvals occur in the DACH region.

Blood Phe Monitoring: Recommended Frequency by Age

Regular blood Phe monitoring is the cornerstone of PKU management. Knowing your current Phe level enables timely responses — whether adjusting the diet, formula dose, or discussing options with your metabolic team. Recommended monitoring frequency depends on age and treatment status.

Age group Recommended frequency
0–1 year (infants) Weekly
1–12 years (children) Every 1–2 weeks
12–18 years (adolescents) Every 2–4 weeks
Adults (stable metabolic control) Every 4–8 weeks
Pregnancy (maternal PKU) Twice per week (or more often)
  • Dry blood spot cards (Guthrie cards) allow simple home testing via fingertip — no clinic visit required for the blood draw
  • Many metabolic centres provide pre-addressed envelopes so home samples can be posted directly to the lab
  • During therapy adjustment or poor metabolic control, even adults may need weekly monitoring
  • PHE Buddy lets you record blood Phe values directly in the app and view your trend as a chart over weeks and months

Blood Phe Target Ranges per International Guidelines

Target blood Phe values are set by age group and pregnancy status. The ranges below are based on the European PKU Guidelines (van Wegberg et al., 2017) and ESKPE recommendations. Individual targets are established by the treating metabolic centre.

Age group Target range (blood Phe)
0–12 years < 360 µmol/L
12–18 years < 600 µmol/L
Adults < 600 µmol/L
Pregnancy 120–360 µmol/L

Note: In maternal PKU, blood Phe should ideally be below 120 µmol/L in the first trimester to minimise the risk of foetal malformations. Pre-conception planning under close supervision from a metabolic centre is strongly recommended.

Regular Appointments at a Metabolic Centre

Alongside ongoing self-monitoring, regular appointments at a specialist metabolic centre are essential. These typically take place every 3–6 months and go beyond a simple blood test.

The multidisciplinary metabolic team

A specialist PKU team typically includes a metabolic specialist (paediatrician or internist with metabolic subspecialty training), a metabolic dietitian, and — particularly for adults and school-age children — a neuropsychologist or psychologist. Together, they review blood Phe trends, dietary logs, formula compliance, and, where indicated, neuropsychological test results. PHE Buddy's doctor portal lets you share dietary data, formula compliance, and blood value trends with the team ahead of each appointment.

  • Regular lab panels: blood Phe, amino acid spectrum, albumin, ferritin, vitamin B12, vitamin D — to detect deficiencies arising from the protein-restricted diet
  • Review and adjustment of the daily Phe limit based on growth, weight, and metabolic trend
  • Discussion of dietary logs and formula compliance — PHE Buddy's doctor portal allows secure sharing of this data before the appointment
  • Where needed: neuropsychology assessment (cognitive tests), nutritional counselling, and social support services

PHE Buddy as Your Treatment Companion: All 3 Pillars Supported

PHE Buddy was developed with patients and metabolic specialists to make the daily demands of PKU therapy as manageable as possible. The app directly supports all three pillars of treatment.

📊
Diet support: Daily Phe tracking
Your individual daily phenylalanine limit (set by your doctor or dietitian) is held centrally. Every meal is deducted in real time — you can see at a glance exactly how much Phe remains for the day.
🍎
BLS 4.0: 7,140 foods with validated Phe values
The integrated BLS 4.0 database contains over 7,140 foods with clinically validated phenylalanine values — the gold standard for the DACH region, fully available offline.
📷
AI nutrition scanner for food labels
Photograph a food label and PHE Buddy automatically calculates the phenylalanine value from the protein content shown. Works for any packaged food, worldwide — no manual arithmetic needed.
Formula support: Tracking and dose reminders
PHE Buddy reminds you at each scheduled formula dose, documents daily intake automatically, and generates compliance reports for clinic appointments and dietitian reviews.
📈
Monitoring support: Blood value logging with trend charts
Enter your Phe results in the app and see your trend as a chart over weeks and months. Identify patterns, spot problem periods, and bring meaningful data to your next metabolic centre appointment.
🩺
Doctor portal for your metabolic team
With your consent, your doctor or dietitian can access your dietary logs, formula compliance, and blood Phe trends directly — enabling better-informed decisions between appointments. GDPR-compliant and revocable at any time.

Make PKU Treatment Easier —
with PHE Buddy

Free for iOS & Android. Beta launch planned for Q3 2026 — join the waitlist now and be among the first users.

Join the Waitlist →

Free · No credit card · PCM Solution GmbH, Austria

Frequently Asked Questions — PKU Treatment

PKU treatment rests on three complementary pillars: (1) Low-phenylalanine diet — strict restriction of natural protein, the cornerstone of therapy since 1953. (2) Amino acid formula — specially developed products supplying all essential amino acids without phenylalanine. (3) Medical therapy — sapropterin/BH4 (Kuvan®) or pegvaliase (Palynziq®) depending on genotype and response. All three are equally important; the formula is as essential as the diet itself, not an optional supplement.
Yes. International PKU guidelines — including the European PKU Guidelines (van Wegberg et al., 2017) and ESKPE recommendations — unambiguously recommend lifelong therapy for all severity levels. The earlier assumption that the diet could be relaxed or stopped after age 8 has been thoroughly disproved by research. Elevated phenylalanine disrupts neurotransmitter synthesis and causes cognitive and neuropsychiatric problems — concentration difficulties, anxiety, and depression — in adults as well as children, often gradually over months before becoming apparent.
Sapropterin (Kuvan®/BH4) is a cofactor for the PAH enzyme and is effective in approximately 20–30% of PKU patients with BH4-responsiveness — predominantly milder forms with residual enzyme activity. Taken orally once daily, it can significantly increase dietary Phe tolerance. Pegvaliase (Palynziq®) is a subcutaneously injected recombinant PAL enzyme, approved for adults with classic PKU who do not respond adequately to BH4. It has a much stronger Phe-lowering effect, but requires a longer titration phase (6–12 months) and careful monitoring for hypersensitivity reactions, including the rare risk of anaphylaxis.
The amino acid formula should be taken 2–4 times daily, spread evenly throughout the day. Distributing doses helps maintain a consistent plasma amino acid level and optimises absorption — taking it all at once is far less effective. Exact dosage (grams of protein equivalent per day) and frequency are set individually by the metabolic team based on age, body weight, and treatment status. PHE Buddy sends reminders for each scheduled dose and tracks compliance automatically, generating reports for clinic appointments.
Recommended targets per current international guidelines are: Children (0–12 years): below 360 µmol/L; Adolescents (12–18 years): below 600 µmol/L; Adults: below 600 µmol/L; Pregnancy: 120–360 µmol/L (ideally below 120 µmol/L in the first trimester). These serve as orientation ranges — the treating metabolic centre sets individual targets based on genotype, residual enzyme activity, and clinical course. PHE Buddy lets you log blood Phe values and see your trend as a chart over time.
PHE Buddy supports all three pillars of PKU treatment: for the diet pillar, it tracks daily Phe intake using the BLS 4.0 database (7,140+ foods with validated Phe values) and an AI nutrition scanner for food labels. For the formula pillar, it sends dose reminders and automatically logs daily intake. For monitoring, it records blood Phe values and displays trend charts over weeks and months. The doctor portal allows you to securely share all this data with your metabolic team between appointments — with your consent, revocable at any time.
Medical note: This page provides general information about PKU treatment and does not replace personalised advice from your metabolic specialist and registered dietitian. All daily phenylalanine limits, formula dosing, therapy adjustments, and treatment decisions must be made in consultation with your clinical team.